A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

NCT04995653 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Allogeneic Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Vancomycin Pre-Treatment
DRUG: Vancomycin Placebo
DRUG: SER-155
DRUG: SER-155 Placebo

Sponsor

Seres Therapeutics, Inc.

Collaborators

[object Object]